The World Health Organization (WHO) has on Friday approved the COVID-29 vaccine developed by Johnson&Johnson, making it an additional 500 million doses to be added to the COVAX global vaccine sharing scheme. The approval comes after Johnson&Johnson’s single jab dose vaccine won approval from the European Union (EU) on Thursday. In a statement, Tedros Ghebreyesus, WHO Chief said “Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic.”
However, the WHO noted that the J&J got an “emergency use lighting” assessing the suitability of the vaccine.
“As new vaccines become available, we must ensure they become part of the global solution, and not another reason some countries and people are left further behind,” Tedros said.
“We hope this new vaccine will help to narrow vaccine inequalities, and not deepen them,” he added.
Meanwhile, the vaccine also received approval from the United States, Canada, and South Africa.